FDA GenAI Medical Device Regulation: Key Considerations Before the October 19, 2026 Comment Deadline

The US FDA is considering a new 'total product lifecycle' approach for regulating medical devices that use Generative AI (GenAI). This episode breaks down the key elements of the FDA's discussion paper, including the unique risks the agency has identified, such as AI 'hallucinations' and automation bias. We discuss why this shift to continuous oversight is being proposed and what it means for manufacturers. Most importantly, we highlight the critical October 19, 2026, deadline for submitting public comment and provide practical steps your team can take now to prepare and help shape future policy. Key Questions: - What is the FDA's proposed regulatory framework for medical devices using Generative AI? - Why is a 'total product lifecycle' approach being considered for GenAI devices? - What specific risks, like hallucinations and automation bias, has the FDA identified? - Who is affected by these potential new regulations? - What is the significance of the October 19, 2026, feedback deadline? - How can manufacturers provide effective feedback to the FDA? - What practical steps should regulatory and quality teams take right now? - How might this framework impact future pre-market submissions and post-market surveillance? Sources: - https://www.medicaldevice-network.com/news/the-fdas-genai-proposal-evolving-regulation-for-an-evolved-medtech-era/ - https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/cdrh-new-news-and-updates How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping you navigate complex requirements like the FDA's evolving stance on AI. Our experts can assist with developing a robust regulatory strategy, preparing technical dossiers for submission, and implementing agile post-market surveillance plans aligned with a lifecycle approach. By combining local expertise with powerful AI and data tools, we streamline global market access and ensure continuous compliance. Contact us at info@pureglobal.com or visit https://pureglobal.com to learn more. Explore our free AI regulatory tools and product database at https://pureglobal.ai.